AstraZeneca in Brussels on 21 April 2021 for digressing from its contract for the supply of the Covid-19 vaccine and for lack of a reliable plan to ensure timely deliveries.
Court hearings were scheduled at end of September 2021. The settlement will pave the way for AstraZeneca to resume deliveries of its vaccine doses to European nations, marred by the lawsuit and concerns over side effects.
It will also help European Union speed up vaccinations. Under the latest agreement, AstraZeneca has committed to deliver 60 million doses of the vaccine by the end of this quarter, 75 million by the end of the fourth quarter 2021 and 65 million by the end of the first quarter 2022.